Animal studies have indicated that GHRH agonists may reduce myocardial infarct scarring in swine [8]
The KidneyIntelX platform utilizes plasma levels of KIM-1, soluble tumor necrosis factor (sTNF) receptor-1, and sTNF receptor-2 to predict diabetic kidney disease progression over 5 years [130] A biomarker panel comprising serum creatinine, osteopontin, tryptase, urea, and estimated glomerular filtration rate (eGFR) achieved an 84.3% accuracy in predicting CKD progression [131] Combining standard markers such as creatinine and cystatin C with sensitive biomarkers such as beta-trace protein (BTP), tissue inhibitor of metalloproteinase-1, TGF-, asymmetric dimethylarginine (ADMA), TNF-, and N-terminal pro-B-type natriuretic peptide (proBNP) have shown improved diagnostic performance for early CKD detection [132] Panels integrating tumor necrosis factor receptor (TNFR)-1, TNFR-2, and KIM-1 have demonstrated superior predictive accuracy for renal function decline The kidney injury test uses urinary markers including cell-free DNA (cfDNA), methylated cfDNA, clusterin, C-X-C motif chemokine ligand 10 (CXCL10), total protein, and creatinine to generate a diagnostic score with high sensitivity and specificity, even when eGFR and proteinuria remain within normal ranges For AKI detection, urinary biomarker panels combining NGAL, KIM-1, cystatin C, and hemojuvelin have shown strong predictive value
At the day 100 of the differentiation of AD organoids, its essential to highlight that the pathology became advanced, potentially leading to severe cell damage due to increase in pathology and the presence of apoptotic bodies
Scr Mater 48:10611066
However, the strains were unable to grow on these peptides
